News
Watch
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Opinion|Videos|April 10, 2024

Bronchiectasis Exacerbation Management

A medical professional explores the management of bronchiectasis exacerbations, detailing the significance of sputum color, the potential for hemoptysis, and the exacerbation of comorbidities such as COPD and asthma.

Episodes in this series

Video 1 - "Overview of Bronchiectasis"

EP. 1 Overview of Bronchiectasis

Video 2 - "Prognosis For Patients Diagnosed With Bronchiectasis"

EP. 2 Prognosis For Patients Diagnosed With Bronchiectasis

Video 3 - "Indicators Leading to Bronchiectasis Testing and Diagnosis"

EP. 3 Indicators Leading to Bronchiectasis Testing and Diagnosis

Video 3 - "Indicators Leading to Bronchiectasis Testing and Diagnosis"

EP. 4 Complications Associated With Bronchiectasis

Video 3 - "Indicators Leading to Bronchiectasis Testing and Diagnosis"

EP. 5 Current Treatment Options For Bronchiectasis

Video 6 - "Respiratory and Physical Therapists Contributing to Comprehensive Bronchiectasis Care"

EP. 6 Respiratory and Physical Therapists Contributing to Comprehensive Bronchiectasis Care

Video 7 - "Key Areas of Research and Emerging Therapies In Bronchiectasis Treatment"

EP. 7 Key Areas of Research and Emerging Therapies In Bronchiectasis Treatment

Video 1 - "Diagnosing and Understanding the Pathogenesis of Bronchiectasis"

EP. 8 Diagnosing and Understanding the Pathogenesis of Bronchiectasis

Video 2 - "Improving Long-Term Outlook: CT Scans and Underdiagnosis of Bronchiectasis"

EP. 9 Improving Long-Term Outlook: CT Scans and Underdiagnosis of Bronchiectasis

Video 10 - "Bronchiectasis Exacerbation Management"

EP. 10 Bronchiectasis Exacerbation Management

Video 11 - "Social Burden and Goals of Therapy for Patients with Bronchiectasis"

EP. 11 Social Burden and Goals of Therapy for Patients with Bronchiectasis

Video 11 - "Social Burden and Goals of Therapy for Patients with Bronchiectasis"

EP. 12 Patient Specific Factors: Guiding Treatment in Bronchiectasis

Video 13 - "Individualized Therapy for Specific Infections Associated with Bronchiectasis"

EP. 13 Individualized Therapy for Specific Infections Associated with Bronchiectasis

Pamela J. McShane, MD, an expert on bronchiectasis

EP. 14 Other Challenges With Bronchiectasis and Key Takeaways

Panagis Galiatsatos, MD, MHS, an expert on bronchiectasis

EP. 15 Identifying Bronchiectasis: Key Clinical Presentations to Consider

Panagis Galiatsatos, MD, MHS, an expert on bronchiectasis

EP. 16 Differentiating Bronchiectasis from COPD and Understanding Exacerbations

Panagis Galiatsatos, MD, MHS, an expert on bronchiectasis

EP. 17 Long-Term Impact of Bronchiectasis Exacerbations: Disease Progression, Patient Outcomes, and Economic Burden

Panagis Galiatsatos, MD, MHS, an expert on bronchiectasis

EP. 18 Managing Bronchiectasis: Treatment Goals, Outcome Measures, and Clinical Decision Resources

Panagis Galiatsatos, MD, MHS, an expert on bronchiectasis

EP. 19 Addressing Knowledge Gaps and Treatment Strategies in Bronchiectasis

Panagis Galiatsatos, MD, MHS, an expert on bronchiectasis

EP. 20 Challenges and Future Directions in Bronchiectasis Management

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

spleen and liver | Image credit: RFBSIP - stock.adobe.com

Selinexor Shows Modest Spleen Response in JAK Inhibitor–Refractory MF

BySkylar Jeremias

August 31st 2026

Brain and lungs. | Image credit: @magicmine_AdobeStock.jpeg

CPFE: Why Spirometry Alone Misses Emphysema in Fibrotic ILD

BySabrina McCrear

August 31st 2026

Expert featured in this series.

New Registry Data on MAC Pulmonary Disease Outcomes

ByAshley Losier, MD

Published: August 31st 2026 | Updated: August 31st 2026

Expert featured in this series.

Top Unmet Needs in MAC Pulmonary Disease Management

ByAshley Losier, MD

Published: August 31st 2026 | Updated: August 31st 2026

DLBCL | Image: Marshall Kadin/ASH Image Bank

20 Years of ADC Trials in Lymphoma Leave Many Questions Unanswered, Authors Say

August 30th 2026

Trending on AJMC

Multiagonists Outpace Older GLP-1 Drugs for Weight Loss

DOJ Abandons Olmstead Defense as Texas v Kennedy Advances

Myasthenia Gravis Linked to Greater Longevity Than Multiple Sclerosis

Midsized Biotechs Strike MFN Drug Pricing Deals

FDA Expands Tirzepatide Label to Reduce Cardiovascular Risk in Type 2 Diabetes